Molecular immunology · 2026
Melatonin ameliorates NEC-associated brain injury by suppressing pro-inflammatory (M1-like) microglia via the AMPK-IL-1β axis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Yijia, Chen Baozhu, Deng Xing, Li Nan, Yang Shiqi, Ma Fei, Zhuang Guiying, Gao Xiaoyan, Xu Miaomiao, Jiang Xiaotao, Wang Lina, Luo Shunchang, Li Sitao
Аннотация
BACKGROUND: Necrotizing enterocolitis (NEC) is a severe neonatal gastrointestinal disease. Its associated brain injury involves neuroinflammation and long-term cognitive impairment, yet specific therapies are lacking. Melatonin (MEL) has shown neuroprotective effects, but its role in NEC-associated brain injury remains unclear.
METHODS: Neonatal C57BL/6 J mice were subjected to NEC induction and studied at short-term (acute) and long-term (chronic, up to 9 weeks). Cognitive function was assessed by Y-maze and open field tests. Microglial activation, inflammatory cytokine expression, and AMPK pathway activity were analyzed in mouse brain tissue and in LPS/IL-1β-stimulated peritoneal macrophages with pharmacological interventions.
RESULTS: Prophylactic MEL improved survival and intestinal injury, and reversed NEC-induced long-term spatial memory deficits. NEC triggered a sustained M1 microglial polarization in the hippocampus that persisted into adulthood, which was durably attenuated by MEL. IL-1β was identified as the most prominently upregulated cytokine, and transcriptomic profiling confirmed enrichment of IL-1β-related pathways. In vitro, recombinant IL-1β directly drove M1 polarization, while IL-1β neutralization blocked this effect. Mechanistically, MEL restored AMPK phosphorylation in NEC brains, and AMPK inhibition abolished the MEL-mediated suppression of M1 polarization.
CONCLUSIONS: Prophylactic MEL ameliorates NEC-associated brain injury by activating AMPK to suppress IL-1β production, thereby inhibiting chronic M1 microglial polarization. This AMPK-IL-1β axis represents a key therapeutic target, with MEL providing dual gut-brain protection.
METHODS: Neonatal C57BL/6 J mice were subjected to NEC induction and studied at short-term (acute) and long-term (chronic, up to 9 weeks). Cognitive function was assessed by Y-maze and open field tests. Microglial activation, inflammatory cytokine expression, and AMPK pathway activity were analyzed in mouse brain tissue and in LPS/IL-1β-stimulated peritoneal macrophages with pharmacological interventions.
RESULTS: Prophylactic MEL improved survival and intestinal injury, and reversed NEC-induced long-term spatial memory deficits. NEC triggered a sustained M1 microglial polarization in the hippocampus that persisted into adulthood, which was durably attenuated by MEL. IL-1β was identified as the most prominently upregulated cytokine, and transcriptomic profiling confirmed enrichment of IL-1β-related pathways. In vitro, recombinant IL-1β directly drove M1 polarization, while IL-1β neutralization blocked this effect. Mechanistically, MEL restored AMPK phosphorylation in NEC brains, and AMPK inhibition abolished the MEL-mediated suppression of M1 polarization.
CONCLUSIONS: Prophylactic MEL ameliorates NEC-associated brain injury by activating AMPK to suppress IL-1β production, thereby inhibiting chronic M1 microglial polarization. This AMPK-IL-1β axis represents a key therapeutic target, with MEL providing dual gut-brain protection.